Specific interest should be placed on continuing to study HGF, procalcitonin, IL-8, IL-2Rα, IP-10, and CXCL-5, as they were the most prevalent biomarkers selected in models of adverse outcomes from CDI in this study. The gene discussed is CXCL8; the disease is clostridium difficile infection.